A non-controlled trial of anti-Tumour Necrotising Factor alpha (anti-TNFa) chimeric monoclonal antibody (Infliximab, Remicade®) in exudative age-related macular degeneration
2013 ◽
Vol 97
(10)
◽
pp. 1273-1276
◽
2009 ◽
Vol 37
(6)
◽
pp. 570-576
◽